---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-25-004953"
form_type: "8-K"
ticker: "BCLI"
cik: "0001137883"
company_name: "BRAINSTORM CELL THERAPEUTICS INC."
filed_at: "2025-01-21T23:59:59+00:00"
generated_at: "2026-05-27T21:53:49.523249+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# BCLI fails to regain Nasdaq MVLS compliance; delisting stayed pending Feb 25 hearing

## Summary
- Company previously failed to meet Nasdaq's minimum market value of listed securities requirement by Jan 14, 2025.
- On Jan 21, 2025, submitted a hearing request to appeal the Staff's delisting determination.
- Nasdaq confirmed hearing on Feb 25, 2025; delisting action is stayed pending final Panel decision.
- Company will present plan to regain compliance and sustain long-term listing criteria.

## SEC filing metadata
- accession: 0001104659-25-004953
- form_type: 8-K
- ticker: BCLI
- cik: 0001137883
- company_name: BRAINSTORM CELL THERAPEUTICS INC.
- filed_at: 2025-01-21T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1137883/000110465925004953/0001104659-25-004953-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1137883/000110465925004953/tm254046d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-25-004953
- JSON: https://secwatch.observer/filing/0001104659-25-004953.json
- Plain text: https://secwatch.observer/filing/0001104659-25-004953.txt

## Source-grounded claims
- claim_id: 8d846cfef13962349aa952de6771fa3547823c98
  claim: BRAINSTORM CELL THERAPEUTICS INC. received a nasdaq hearing update notice regarding market value.
  evidence_excerpt: January 21, 2025, the Company submitted a hearing request to the Nasdaq Hearings Panel (the “Panel”) to appeal the Staff’s determination. On the same day, the Company received a letter from Nasdaq notifying the Company t
  evidence_url: https://www.sec.gov/Archives/edgar/data/1137883/000110465925004953/0001104659-25-004953-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.